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ABSTRACT
Objective: To examine the effects of anxiety on 
neuropsychological performance among HIV positive 
adults in Lusaka, Zambia. 
Design: A cross-sectional study with a sample of 263 
participants of who 107 (40.7%) were males and 156 
(59.3%) were females. 
Measures: The International Neurobehavioural Test 
Battery and Beck Anxiety Inventory were used to assess 
cognitive performance and anxiety levels respectively. 
Results: Severe anxiety showed a weak positive 
correlation (r=.148, p=0.472), but the result did not reach 
statistical significance. Participants who were not able to 
perform instrumental activities of daily living 
independently were more likely to be anxious (p<0.05). 
Conclusion: Results obtained from this study imply that 
there are minimal differences in performance between 
non anxious and anxious HIV positive individuals on 
neurocognitive performance. However, anxiety showed 
an effect on instrumental activities of daily living of the 
participants. 
INTRODUCTION 
It is important to recognise and treat anxiety in the HIV 
positive population because it has been associated with 
poor treatment compliance, disease progression leading 
1to increased use of the health care services.  Anxiety takes 
up cognitive capacity and leaves less attention resources 
2for tasks leading to poor cognitive performance.   High 
arousal of anxiety may lead to mental problems such as, 
slowing, scrambled or blocked thoughts and words, and 
memory failure which can interfere with one's 
3  performance on neuropsychological assessment. This 
can disturb the patient's ability in almost all areas of 
3,4cognitive functioning  attributed this to the general 
worry associated with anxiety which impairs attention on 
demanding tasks. However, little is known regarding the 
relationship between anxiety and cognitive functions and 
5that the reported observations are inconclusive.  
6Moreover, the literature is mixed.  There is a knowledge 
gap regarding cognitive functions. Therefore, this study 
will seek to extend the current literature by clarifying 
nature on neurocognitive functioning in a medical 
sample, aid in the management of HIV positive 
individuals as the associated anxiety will be recognised 
and treated, and determine effects of anxiety on 
instrumental activities of daily living (IADL).
Therefore, this study will be carried out to explore the role 
of HIV related anxiety on neurocognitive functioning 
aimed at examining the effects of HIV infection and HIV 
related anxiety on neuropsychological performance. The 
specific objectives were to identify neurocognitive 
deficits associated with HIV related anxiety and 
determine effects of HIV related anxiety and cognitive 
performance on Instrumental activities of daily living.
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A total of 263 participants were recruited from the 
antiretroviral clinic across Lusaka (Matero main, Matero 
reference, Chipata, Kalingalinga, Chilenje and Kabwata 
clinics) with permission from the Ministry of Health. 
Inclusion criteria was a minimum of 5 years of education, 
age range of 18 to 65 years, no neurological impairment 
as determined by the neurobehavioural medical screen 
and no history of alcohol abuse. Participants were 
identified by the nurses at the respective clinics after 




A medical Doctor was assigned to conduct clinical 
assessments that included physical examinations to 
determine the WHO staging of the participants and rule 
out neurological disorders that could have had an impact 
on neurocognitive performance.  
Neuropsychological Assessment           
Ten graduate students assessed the participants using the 
neurobehavioural medical screen, Beck Anxiety 
Inventory, Activities of Daily Living questionnaire, 
substance use history and behavioural notes prior to 
administering the International Neurobehavioural Test 
Battery (Table 1).
Table 1: Neuropsychological Domains and Tests
Ethical Considerations
Ethical approval was obtained from University of Zambia, 
Biomedical Research Ethics Committee (UNZABREC). 
Confidentiality was maintained by storing identifying 
data separately from the data. Both written and verbal 
informed consent were obtained from the participants 
before the tests were administered.
Data Analysis and Management
Statistical Package for Social Sciences (SPSS) version 16 
was used for data analysis. The raw data obtained from the 
study was converted into T- Scores to correct for age, 
education and gender to ensure effects seen were not due 
to any of these factors.
RESULTS
Participants 
The participants consisted of 107 (40.7%) males and 156 
(59.3%) females. Participants' educational level ranged 
from 5 to 20 years. The ages ranged from 21 to 65 years old 
with a mean age of 40.78 and SD of 8.9. The majority of 
the participants were in stage III WHO staging (45.4%), 
followed by 28% in WHO stage I, 20.3% in stage II while 
6.3% were in WHO stage IV.  A total of 66.5 % (175) did 
not show impairment on cognitive performance whilst 
33.5 % (88) were impaired. 
Anxiety and Neurocognitive Functioning
A weak positive correlation (r=0.148, p=0.472) was seen 
between severe anxiety and neurocognitive performance 
using Pearson correlation coefficient, though the strength 
of the relation was small and not statistically significant. 
Anxiety, age, WHO staging and CD4 count were included 
in the standard multiple regression analysis as they can 
also impact on neurocognitive performance. Anxiety did 
not reach statistical significance (p>0.05) on cognitive 
performance, indicating that anxiety did not make a 
unique contribution to neurocognitive performance. 
However, age reached statistical significance on verbal 
fluency (p=0.046), learning (p=0.011), and the recall 
domain, meaning it made a unique contribution on 
cognitive performance. CD4 count also reached statistical 
significance on speed of information processing (0.037) 
and the global mean (0.007). However, WHO staging 
Cognitive Domain   




WAIS-III Digit Symbol 
WAIS-III Symbol Search 
Trail Making Test Part A  





Hopkins Verbal Learning Test, Revised -II)




Paced Auditory Serial Addition Test





Word Sound Fluency 
Category Fluency
Abstraction/Executive 
Functioning     
 
Wisconsin Card Sorting Test (64 -item 
version) 
Color Trails 
Stroop Color Word Test 
Category Tests – Computer version
Motor Grooved Pegboard 




Academic Skills Questionnaire Zambia 
Achievement Test
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(p>0.05) did not reach statistical significance on any of the 
seven cognitive domain assessed (speed of information 
processing, working memory, language, executive 
functioning, learning, delayed recall and motor domain), 
indicating that it had no effect on cognitive functioning. 
Anxiety and Neurocognitive Functioning on 
Instrumental Activities of Daily Living
A total of 91.7 % (188) were able to perform IADLs 
independently while 8.3 (17) needed help with IADLs. 
Results from a logistic regression to determine the effects 
of anxiety and neurocognitive functioning on IADLs 
reached statistical significance on cognitive performance 
(Table 2). The result revealed that those who had 
problems with IADL were more likely to be anxious. 
Table 2:  Anxiety and Neurocognitive Performance on 
IADLs 
DISCUSSION
Anxiety did not have an effect on the performance on any 
of the seven cognitive domains assessed, despite 43 % of 
the participants showing anxiety. This result could have 
occurred due to participants over reporting the anxiety 
symptoms which was assessed using a self administered 
questionnaire. Previous studies have shown that when one 
does not view the assessment as a threat, cognitive 
8  dysfunction may not be seen. The threat was responsible 
























































.031 .349 1 .555 .98
Anxiety .040 .017 5.508 1 .019 1.04
Motor -.058 .027 4.502 1 .034 .94
Anxiety .035 .017 4.511 1 .034 1.04
SIP -.037 .038 ,963 1 .326 .96
Anxiety .039 .017 5.394 1 .020 1.04
for distracting the participants leading to poor 
performance as it impaired participant's attention and 
concentration on the task. A weak positive correlation 
(r=.148, p= 0.478) was seen, but did not reach statistical 
significance and was of a small strength. It can thus be 
said that these findings appear consistent with previous 
8studies .  reported a similar result, which did not show a 
significant effect of anxiety on cognitive performance but 
suggested that severe anxiety was associated with worse 
cognition. Anxiety had an effect on cognitive 
9performance when the task was complex .   The adverse 
effects of anxiety increase as the task complexity 
increases and impair response time and not the accuracy 
10. These results could have differed with the current study 
in that not all the tests used in the current study were time 
oriented which seems to be affected by anxiety but were 
based on accuracy which has been reported not to be 
5affected by anxiety. On the contrary,  reported that 
anxiety and mild depression showed significant deficits 
in episodic memory functioning and impaired executive 
functioning. The result could have been attributed to the 
presence of comorbid depression which could have 
accounted for the poor cognitive performance. Although 
the results obtained from this study seem not to imply that 
there may be some cognitive deficits associated with HIV 
related anxiety, literature has shown that it is important to 
recognise and treat anxiety in the HIV positive population 
because it has been associated with poor treatment 
compliance, high risk behaviours, disease progression 
1and increased use of the health care services.  Anxiety has 
also been reported to take up cognitive capacity leaving 
less attentional resources for the tasks which in turn lead 
2to poor cognitive performance.  Based on this 
information, it is proposed that HIV patients are screened 
for anxiety and appropriate intervention taken.
This study revealed that anxiety contributed significantly 
to one having problems with performing IADL on all 
domains (p<.05). This is in line with previous studies that 
revealed similar findings. A study done showed that 
anxiety and cognition were significant on the IADL (p= 
110.024) . This result however, could have occurred 
because the participants were also depressed and 
physically ill which could have further impacted on their 
cognitive abilities. Anxiety disorder was associated with 
12an increased risk of incident IADL limitation (p=0.048).    
IADL limitations could have been as a result of 
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participants' age. Results obtained from this study cannot 
be generalized as the sample size for participants who 
were IADL dependent was small (n=17). Further studies 
need to be done on a larger sample to determine the effects 
of HIV related anxiety and cognitive performance on 
IADL. However, this study has confirmed that HIV 
related anxiety is a strong predictor of one being IADL 
dependent, it is therefore important that anxiety in HIV is 
considered in the assessment and treatment of HIV 
positive individuals. 
CONCLUSION
Results obtained from this study imply that HIV related 
anxiety has no effect on cognitive performance, though 
severe anxiety showed a weak positive correlation (r = 
.148) of small strength. Hence, it is expected that anxious 
and non anxious patients will perform the same on the test 
battery. However, it is recommended that HIV patients are 
screened for anxiety as this study revealed that anxiety 
was a strong predictor on one's IADL status and reached 
statistical significance (p<.05) which can have an 
implication on one's daily functioning.
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